| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |